Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization

Background: Stereotactic ablative radiotherapy (SABR) can deliver tumoricidal doses and achieve long-term control in early hepatocellular carcinoma (HCC). However, limited studies have investigated the safety and effectiveness of SABR in patients with advanced diseases that is unsuitable for transar...

Full description

Bibliographic Details

Published in:	Therapeutic Advances in Medical Oncology
Main Authors:	Hsin-Lun Lee, Jo-Ting Tsai, Chun-You Chen, Ying-Chun Lin, Chin-Beng Ho, Lai-Lei Ting, Chia-Chun Kuo, I-Chun Lai, Chun-Yu Lin, Jui-Hsiang Tang, Yu-Min Huang, Wei-Yu Kao, Sheng-Wei Cheng, Chia-Ning Shen, Shang-Wen Chen, Jeng-Fong Chiou
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-12-01
Online Access:	https://doi.org/10.1177/1758835919889002